Armistice Capital, LLC Nuvation Bio Inc. Transaction History
Armistice Capital, LLC
- $6.51 Billion
- Q3 2025
A detailed history of Armistice Capital, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 2,296,000 shares of NUVB stock, worth $11.2 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
2,296,000
Previous 500,000
359.2%
Holding current value
$11.2 Million
Previous $975,000
771.28%
% of portfolio
0.13%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding NUVB
# of Institutions
217Shares Held
165MCall Options Held
1.99MPut Options Held
660K-
Decheng Capital LLC Menlo Park, CA26MShares$126 Million16.75% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$78.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$75.1 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY9.71MShares$47.2 Million0.67% of portfolio
-
Omega Fund Management, LLC Boston, MA8.83MShares$42.9 Million89.01% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $1.06B
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...